Market News

Global Dry Eye Syndrome Treatment Market to Witness CAGR of 6.8% in the Forecast Period of 2019 to 2026

According to Data Bridge Market Research the dry eye syndrome treatment market in developing regions is witnessing a growth in terms of its adoption rate, due to rising usage of contact lenses, increasing awareness about the treatment of the disease, increasing ageing population and rising demand of lasik surgery.

Now the question is which are the regions that dry eye syndrome treatment market players should target? Data Bridge Market Research has forecasted market leaders to target North America developing regions to help them in attaining better volume of revenue generation.

Scope of the Dry Eye Syndrome Treatment Market

Dry eye syndrome treatment market on the basis of countries is segmented into U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.

Dry Eye Syndrome Treatment Market Developments

Sun Pharmaceutical announced the launch of Cequa in October 2019 which is specially designed for the treatment of the dry eye disease. This launch will help the company to enhance their portfolio and provide better treatment options to the customers worldwide.

Dry Eye Syndrome Treatment Market is forecasted to grow at 6.8% for 2019 to 2026 with factors such as lack of skilled ophthalmologists and strict regulatory process is expected to hamper the market growth.

Dry eye syndrome treatment market has shown a significant adoption rate and preferences from the North America region with countries such as U.S. and Canada.  Increasing cases of dry eye syndrome in the region is expected to enhance the demand for the dry eye syndrome treatment.

Key Pointers Covered in the Dry Eye Syndrome Treatment Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • ALLERGAN
  • Novartis AG
  • Bausch & Lomb Incorporated
  • Santen Pharmaceutical Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Akorn, Incorporated
  • Alcon Inc.
  • Alembic Pharmaceuticals Limited
  • Cardinal Health
  • Cipla Inc.
  • Horus Pharma
  • Hubrx
  • Novaliq GmbH
  • Perrigo Company plc
  • Prestige Consumer Healthcare, Inc.
  • ROHTO Pharmaceutical Co., Ltd
  • Senju Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • TevaPharmaceutical Industries Ltd.
  • VISUfarma


Leave a Reply